0.00 NA (NA%)
0 XNAS Volume
XNAS 20 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Kristi Jones | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Jun 2024 | 1 | 1 | - | 0 | Series A Preferred Stock, par value $0.0001 per share | |
| Sol J. Barer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2023 | 44,983 | 44,983 | - | - | Stock Option (right to buy) | |
| Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2023 | 44,983 | 44,983 | - | - | Stock Option (right to buy) | |
| Timothy Bertram | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2023 | 44,983 | 44,983 | - | - | Stock Option (right to buy) | |
| Paul D’Angio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2023 | 44,983 | 44,983 | - | - | Stock Option (right to buy) | |
| Grant Verstandig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2023 | 44,983 | 44,983 | - | - | Stock Option (right to buy) | |
| Leena Gandhi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2023 | 44,983 | 44,983 | - | - | Stock Option (right to buy) | |
| Sol J. Barer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 19,113 | 19,113 | - | - | Stock Option (right to buy) | |
| Sol J. Barer | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 61,678 | 0 | - | - | Stock Option (right to buy) | |
| Sol J. Barer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 155,900 | 155,900 | - | - | Stock Option (right to buy) | |
| Sol J. Barer | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 155,900 | 0 | - | - | Stock Option (right to buy) | |
| Sol J. Barer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 61,678 | 61,678 | - | - | Stock Option (right to buy) | |
| Sol J. Barer | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 19,113 | 0 | - | - | Stock Option (right to buy) | |
| Alan S. Roemer | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 61,678 | 0 | - | - | Stock Option (right to buy) | |
| Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 3,856 | 3,856 | - | - | Stock Option (right to buy) | |
| Alan S. Roemer | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 3,856 | 0 | - | - | Stock Option (right to buy) | |
| Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 23,122 | 23,122 | - | - | Stock Option (right to buy) | |
| Alan S. Roemer | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 23,122 | 0 | - | - | Stock Option (right to buy) | |
| Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 9,556 | 9,556 | - | - | Stock Option (right to buy) | |
| Alan S. Roemer | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 9,556 | 0 | - | - | Stock Option (right to buy) | |
| Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 61,678 | 61,678 | - | - | Stock Option (right to buy) | |
| Timothy Bertram | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 61,678 | 0 | - | - | Stock Option (right to buy) | |
| Timothy Bertram | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 23,122 | 0 | - | - | Stock Option (right to buy) | |
| Timothy Bertram | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 23,122 | 23,122 | - | - | Stock Option (right to buy) | |
| Timothy Bertram | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 12,634 | 12,634 | - | - | Stock Option (right to buy) | |
| Timothy Bertram | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 12,634 | 12,634 | - | - | Stock Option (right to buy) | |
| Timothy Bertram | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 9,556 | 9,556 | - | - | Stock Option (right to buy) | |
| Timothy Bertram | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 9,556 | 0 | - | - | Stock Option (right to buy) | |
| Timothy Bertram | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 61,678 | 61,678 | - | - | Stock Option (right to buy) | |
| John Trainer | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 78,100 | 0 | - | - | Stock Option (right to buy) | |
| John Trainer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 13,727 | 13,727 | - | - | Stock Option (right to buy) | |
| John Trainer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 89,222 | 89,222 | - | - | Stock Option (right to buy) | |
| John Trainer | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 102,949 | 0 | - | - | Stock Option (right to buy) | |
| John Trainer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 10,267 | 10,267 | - | - | Stock Option (right to buy) | |
| John Trainer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 18,720 | 18,720 | - | - | Stock Option (right to buy) | |
| John Trainer | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 28,987 | 0 | - | - | Stock Option (right to buy) | |
| John Trainer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 50,440 | 50,440 | - | - | Stock Option (right to buy) | |
| John Trainer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 27,660 | 27,660 | - | - | Stock Option (right to buy) | |
| John Trainer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 89,100 | 89,100 | - | - | Stock Option (right to buy) | |
| Kristi Jones | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 15,743 | 15,743 | - | - | Stock Option (right to buy) | |
| Kristi Jones | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 300,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Kristi Jones | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 456,000 | 0 | - | - | Stock Option (right to buy) | |
| Kristi Jones | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 161,500 | 161,500 | - | - | Stock Option (right to buy) | |
| Kristi Jones | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 294,500 | 294,500 | - | - | Stock Option (right to buy) | |
| Kristi Jones | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 84,207 | 0 | - | - | Stock Option (right to buy) | |
| Kristi Jones | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 54,383 | 54,383 | - | - | Stock Option (right to buy) | |
| Kristi Jones | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 29,824 | 29,824 | - | - | Stock Option (right to buy) | |
| Kristi Jones | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 18,824 | 0 | - | - | Stock Option (right to buy) | |
| Kristi Jones | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 18,824 | 18,824 | - | - | Stock Option (right to buy) | |
| Kristi Jones | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 24,499 | 0 | - | - | Stock Option (right to buy) | |
| Kristi Jones | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 24,499 | 24,499 | - | - | Stock Option (right to buy) | |
| Kristi Jones | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 3,715 | 0 | - | - | Stock Option (right to buy) | |
| Kristi Jones | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 3,715 | 3,715 | - | - | Stock Option (right to buy) | |
| Kristi Jones | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 88,156 | 0 | - | - | Stock Option (right to buy) | |
| Kristi Jones | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 88,156 | 88,156 | - | - | Stock Option (right to buy) | |
| Kristi Jones | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 15,743 | 0 | - | - | Stock Option (right to buy) | |
| Paul D’Angio | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 9,556 | 0 | - | - | Stock Option (right to buy) | |
| Paul D’Angio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 61,678 | 61,678 | - | - | Stock Option (right to buy) | |
| Paul D’Angio | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 61,678 | 0 | - | - | Stock Option (right to buy) | |
| Paul D’Angio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 23,122 | 23,122 | - | - | Stock Option (right to buy) | |
| Paul D’Angio | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 12,634 | 0 | - | - | Stock Option (right to buy) | |
| Paul D’Angio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 12,634 | 12,634 | - | - | Stock Option (right to buy) | |
| Paul D’Angio | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 23,122 | 0 | - | - | Stock Option (right to buy) | |
| Paul D’Angio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 9,556 | 9,556 | - | - | Stock Option (right to buy) | |
| Grant Verstandig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 5,430 | 5,430 | - | - | Stock Option (right to buy) | |
| Grant Verstandig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 61,678 | 61,678 | - | - | Stock Option (right to buy) | |
| Grant Verstandig | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 39,096 | 0 | - | - | Stock Option (right to buy) | |
| Grant Verstandig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 33,666 | 33,666 | - | - | Stock Option (right to buy) | |
| Grant Verstandig | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 61,678 | 0 | - | - | Stock Option (right to buy) | |
| Mathias Oelke | Chief Science Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 31,948 | 0 | - | - | Stock Option (right to buy) | |
| Mathias Oelke | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 7,050 | 7,050 | - | - | Stock Option (right to buy) | |
| Mathias Oelke | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 15,793 | 15,793 | - | - | Stock Option (right to buy) | |
| Mathias Oelke | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 47,379 | 47,379 | - | - | Stock Option (right to buy) | |
| Mathias Oelke | Chief Science Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 15,793 | 0 | - | - | Stock Option (right to buy) | |
| Mathias Oelke | Chief Science Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 47,379 | 0 | - | - | Stock Option (right to buy) | |
| Mathias Oelke | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 38,750 | 38,750 | - | - | Stock Option (right to buy) | |
| Mathias Oelke | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 21,250 | 21,250 | - | - | Stock Option (right to buy) | |
| Mathias Oelke | Chief Science Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 60,000 | 0 | - | - | Stock Option (right to buy) | |
| Mathias Oelke | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 81,100 | 81,100 | - | - | Stock Option (right to buy) | |
| Mathias Oelke | Chief Science Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 19,905 | 0 | - | - | Stock Option (right to buy) | |
| Mathias Oelke | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 12,855 | 12,855 | - | - | Stock Option (right to buy) | |
| Mathias Oelke | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 115,051 | 115,051 | - | - | Stock Option (right to buy) | |
| Mathias Oelke | Chief Science Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 115,051 | 0 | - | - | Stock Option (right to buy) | |
| Mathias Oelke | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 4,755 | 4,755 | - | - | Stock Option (right to buy) | |
| Mathias Oelke | Chief Science Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 4,755 | 0 | - | - | Stock Option (right to buy) | |
| Mathias Oelke | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 31,948 | 31,948 | - | - | Stock Option (right to buy) | |
| Leena Gandhi | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 80,947 | 0 | - | - | Stock Option (right to buy) | |
| Leena Gandhi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 44,971 | 44,971 | - | - | Stock Option (right to buy) | |
| Leena Gandhi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 35,976 | 35,976 | - | - | Stock Option (right to buy) | |
| Sol J. Barer | Director | Purchase of securities on an exchange or from another person at price $ 0.41 per share. | 30 Mar 2023 | 400,000 | 2,217,814 | - | 0.4 | 164,120 | Common Stock |
| Kristi Jones | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 296,700 | 369,778 | - | 0 | Common Stock | |
| John Trainer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2022 | 125,200 | 186,969 | - | 0 | Common Stock | |
| Mathias Oelke | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2022 | 126,100 | 134,023 | - | 0 | Common Stock | |
| Sol J. Barer | Director | Purchase of securities on an exchange or from another person at price $ 0.48 per share. | 16 Nov 2022 | 75,000 | 1,817,814 | - | 0.5 | 35,918 | Common Stock |
| Sol J. Barer | Director | Purchase of securities on an exchange or from another person at price $ 0.48 per share. | 16 Nov 2022 | 125,000 | 1,742,814 | - | 0.5 | 60,300 | Common Stock |
| Sol J. Barer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 61,678 | 61,678 | - | - | Stock Option (Right to Buy) | |
| Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 61,678 | 61,678 | - | - | Stock Option (Right to Buy) | |
| Timothy Bertram | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 61,678 | 61,678 | - | - | Stock Option (Right to Buy) | |
| Paul D’Angio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 61,678 | 61,678 | - | - | Stock Option (Right to Buy) | |
| Grant Verstandig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 61,678 | 61,678 | - | - | Stock Option (Right to Buy) | |
| Grant Verstandig | Director | Purchase of securities on an exchange or from another person at price $ 2.14 per share. | 03 Jun 2022 | 25,000 | 1,078,619 | - | 2.1 | 53,538 | Common Stock |
| Grant Verstandig | Director | Purchase of securities on an exchange or from another person at price $ 2.22 per share. | 03 Jun 2022 | 15,000 | 1,053,619 | - | 2.2 | 33,374 | Common Stock |
| Grant Verstandig | Director | Purchase of securities on an exchange or from another person at price $ 2.28 per share. | 03 Jun 2022 | 26,876 | 1,105,495 | - | 2.3 | 61,385 | Common Stock |
| Sol J. Barer | Director | Purchase of securities on an exchange or from another person at price $ 2.22 per share. | 31 May 2022 | 20,720 | 1,617,814 | - | 2.2 | 46,100 | Common Stock |
| Sol J. Barer | Director | Purchase of securities on an exchange or from another person at price $ 2.19 per share. | 31 May 2022 | 39,280 | 1,557,094 | - | 2.2 | 85,894 | Common Stock |
| Sol J. Barer | Director | Purchase of securities on an exchange or from another person at price $ 2.35 per share. | 31 May 2022 | 40,000 | 1,597,094 | - | 2.4 | 94,160 | Common Stock |
| Grant Verstandig | Director | Purchase of securities on an exchange or from another person at price $ 2.23 per share. | 31 May 2022 | 47,900 | 1,038,619 | - | 2.2 | 106,683 | Common Stock |
| Grant Verstandig | Director | Purchase of securities on an exchange or from another person at price $ 2.11 per share. | 31 May 2022 | 45,024 | 950,519 | - | 2.1 | 95,118 | Common Stock |
| Grant Verstandig | Director | Purchase of securities on an exchange or from another person at price $ 2.38 per share. | 31 May 2022 | 40,200 | 990,719 | - | 2.4 | 95,760 | Common Stock |
| Leena Gandhi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 80,947 | 80,947 | - | - | Stock Option (Right to Buy) | |
| Jerome Bernard Zeldis | Executive VP of Research & Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 80,100 | 80,100 | - | - | Stock Option (Right to Buy) | |
| John Trainer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 78,100 | 78,100 | - | - | Stock Option (Right to Buy) | |
| Kristi Jones | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 456,000 | 456,000 | - | - | Stock Option (Right to Buy) | |
| Robert Knight | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 48,000 | 48,000 | - | - | Stock Options (Right to Buy) | |
| Mathias Oelke | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Kristi Jones | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.74 per share. | 29 Mar 2022 | 10,000 | 73,078 | - | 3.7 | 37,400 | Common Stock |
| Grant Verstandig | Director | Purchase of securities on an exchange or from another person at price $ 4.14 per share. | 24 Mar 2022 | 131,622 | 886,512 | - | 4.1 | 544,915 | Common Stock |
| Grant Verstandig | Director | Purchase of securities on an exchange or from another person at price $ 3.76 per share. | 24 Mar 2022 | 18,983 | 905,495 | - | 3.8 | 71,376 | Common Stock |
| Grant Verstandig | Director | Purchase of securities on an exchange or from another person at price $ 3.35 per share. | 24 Mar 2022 | 39,995 | 754,890 | - | 3.3 | 133,983 | Common Stock |
| Sol J. Barer | Director | Purchase of securities on an exchange or from another person at price $ 2.67 per share. | 23 Mar 2022 | 10,000 | 1,517,814 | - | 2.7 | 26,653 | Common Stock |
| Sol J. Barer | Director | Purchase of securities on an exchange or from another person at price $ 2.41 per share. | 22 Mar 2022 | 30,000 | 1,507,814 | - | 2.4 | 72,300 | Common Stock |
| Sol J. Barer | Director | Purchase of securities on an exchange or from another person at price $ 2.14 per share. | 21 Mar 2022 | 30,000 | 1,477,814 | - | 2.1 | 64,080 | Common Stock |
| Sol J. Barer | Director | Purchase of securities on an exchange or from another person at price $ 2.11 per share. | 18 Mar 2022 | 30,000 | 1,447,814 | - | 2.1 | 63,210 | Common Stock |
| Sol J. Barer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share. | 21 Dec 2021 | 50,000 | 1,417,814 | - | 5.2 | 258,500 | Common Stock |
| Sol J. Barer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2021 | 50,000 | 155,900 | - | - | Stock Option (right to buy) | |
| Alan S. Roemer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.31 per share. | 21 Dec 2021 | 42,389 | 195,641 | - | 4.3 | 182,697 | Common Stock |
| Alan S. Roemer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.58 per share. | 21 Dec 2021 | 12,634 | 153,252 | - | 2.6 | 32,596 | Common Stock |
| Alan S. Roemer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 21 Dec 2021 | 12,634 | 140,618 | - | 2.4 | 30,574 | Common Stock |
| Alan S. Roemer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2021 | 42,389 | 3,856 | - | - | Stock Option (right to buy) | |
| Alan S. Roemer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2021 | 12,634 | 0 | - | - | Stock Option (right to buy) | |
| Alan S. Roemer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2021 | 12,634 | 0 | - | - | Stock Option (right to buy) | |
| John Trainer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2021 | 3,432 | 102,949 | - | - | Stock Option (right to buy) | |
| John Trainer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share. | 08 Jul 2021 | 3,432 | 61,770 | - | 5.2 | 17,743 | Common Stock |
| John Trainer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2021 | 3,432 | 106,381 | - | - | Stock Option (right to buy) | |
| John Trainer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share. | 08 Jun 2021 | 3,432 | 58,338 | - | 5.2 | 17,743 | Common Stock |
| John Trainer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share. | 08 Apr 2021 | 3,432 | 54,906 | - | 5.2 | 17,743 | Common Stock |
| John Trainer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2021 | 3,432 | 109,813 | - | - | Stock Option (right to buy) | |
| John Trainer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2021 | 3,432 | 113,245 | - | - | Stock Option (right to buy) | |
| John Trainer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share. | 08 Apr 2021 | 3,432 | 51,474 | - | 5.2 | 17,743 | Common Stock |
| John Trainer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2021 | 3,432 | 116,677 | - | - | Stock Option (right to buy) | |
| John Trainer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share. | 10 Mar 2021 | 3,432 | 48,042 | - | 5.2 | 17,743 | Common Stock |
| Sol J. Barer | Director | 17 Feb 2021 | 894,036 | 894,036 | - | - | Common Stock | ||
| Sol J. Barer | Director | 17 Feb 2021 | 217,570 | 0 | - | - | Series A Preferred Stock | ||
| Sol J. Barer | Director | 17 Feb 2021 | 82,204 | 0 | - | - | Series A3 Preferred Stock | ||
| Sol J. Barer | Director | 17 Feb 2021 | 164,408 | 0 | - | - | Series A2 Preferred Stock | ||
| Sol J. Barer | Director | 17 Feb 2021 | 894,036 | 0 | - | - | Series A Preferred Stock | ||
| Sol J. Barer | Director | 17 Feb 2021 | 800,182 | 0 | - | - | Series A Preferred Stock | ||
| Sol J. Barer | Director | 17 Feb 2021 | 217,570 | 346,577 | - | - | Common Stock | ||
| Sol J. Barer | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 17 Feb 2021 | 60,000 | 1,538,013 | - | 17 | 1,020,000 | Common Stock |
| Sol J. Barer | Director | 17 Feb 2021 | 337,365 | 1,478,013 | - | - | Common Stock | ||
| Sol J. Barer | Director | 17 Feb 2021 | 82,204 | 1,140,648 | - | - | Common Stock | ||
| Sol J. Barer | Director | 17 Feb 2021 | 164,408 | 1,058,444 | - | - | Common Stock | ||
| Sol J. Barer | Director | 17 Feb 2021 | 800,182 | 1,367,814 | - | - | Common Stock | ||
| Alan S. Roemer | Director | 17 Feb 2021 | 26,590 | 115,716 | - | - | Common Stock | ||
| Alan S. Roemer | Director | 17 Feb 2021 | 12,268 | 127,984 | - | - | Common Stock | ||
| Alan S. Roemer | Director | 17 Feb 2021 | 85,016 | 0 | - | - | Series A Preferred Stock | ||
| Alan S. Roemer | Director | 17 Feb 2021 | 26,590 | 0 | - | - | Series A3 Preferred Stock | ||
| Alan S. Roemer | Director | 17 Feb 2021 | 4,110 | 0 | - | - | Series A2 Preferred Stock | ||
| Alan S. Roemer | Director | 17 Feb 2021 | 85,016 | 85,016 | - | - | Common Stock | ||
| Alan S. Roemer | Director | 17 Feb 2021 | 4,110 | 89,126 | - | - | Common Stock | ||
| Jerome Bernard Zeldis | Executive VP of Research & Dev | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 17 Feb 2021 | 5,882 | 5,882 | - | 17 | 99,994 | Common Stock |
| Timothy Bertram | Director | 17 Feb 2021 | 16,440 | 0 | - | - | Series A3 Stock | ||
| Timothy Bertram | Director | 17 Feb 2021 | 10,344 | 0 | - | - | Series A2 Preferred Stock | ||
| Timothy Bertram | Director | 17 Feb 2021 | 44,965 | 0 | - | - | Series A Preferred Stock | ||
| Timothy Bertram | Director | 17 Feb 2021 | 16,440 | 78,199 | - | - | Common Stock | ||
| Timothy Bertram | Director | 17 Feb 2021 | 10,344 | 61,759 | - | - | Common Stock | ||
| Timothy Bertram | Director | 17 Feb 2021 | 44,965 | 51,415 | - | - | Common Stock | ||
| Scott Carmer | Director, President and CEO | 17 Feb 2021 | 7,058 | 7,058 | - | - | Common Stock | ||
| Scott Carmer | Director, President and CEO | 17 Feb 2021 | 7,058 | 0 | - | - | Series A Preferred Stock | ||
| Kristi Jones | Chief Operating Officer | 17 Feb 2021 | 14,738 | 62,167 | - | - | Common Stock | ||
| Kristi Jones | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 17 Feb 2021 | 911 | 63,078 | - | 17 | 15,487 | Common Stock |
| Kristi Jones | Chief Operating Officer | 17 Feb 2021 | 14,738 | 0 | - | - | Series A Preferred Stock | ||
| Paul D’Angio | Director | 17 Feb 2021 | 19,627 | 0 | - | - | Series A Preferred Stock | ||
| Paul D’Angio | Director | 17 Feb 2021 | 19,627 | 19,627 | - | - | Common Stock | ||
| Paul D’Angio | Director | 17 Feb 2021 | 4,110 | 23,737 | - | - | Common Stock | ||
| Paul D’Angio | Director | 17 Feb 2021 | 4,110 | 27,847 | - | - | Common Stock | ||
| Paul D’Angio | Director | 17 Feb 2021 | 4,110 | 0 | - | - | Series A2 Preferred Stock | ||
| Paul D’Angio | Director | 17 Feb 2021 | 4,110 | 0 | - | - | Series A3 Preferred Stock | ||
| Grant Verstandig | Director | 17 Feb 2021 | 539,895 | 539,895 | - | - | Common Stock | ||
| Grant Verstandig | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 17 Feb 2021 | 175,000 | 714,895 | - | 17 | 2,975,000 | Common Stock |
| Sol J. Barer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 19,113 | 225,013 | - | - | Stock Option (right to buy) | |
| Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 9,556 | 104,191 | - | - | Stock Option (right to buy) | |
| Jerome Bernard Zeldis | Executive VP of Research & Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 351,016 | 351,016 | - | - | Stock Option (right to buy) | |
| Timothy Bertram | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 9,556 | 45,312 | - | - | Stock Option (right to buy) | |
| Scott Carmer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 306,842 | 770,923 | - | - | Stock Option (right to buy) | |
| John Trainer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 28,987 | 149,096 | - | - | Stock Option (right to buy) | |
| Kristi Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 84,207 | 235,144 | - | - | Stock Option (right to buy) | |
| Robert Knight | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 210,609 | 210,609 | - | - | Stock Option (right to buy) | |
| Paul D’Angio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 9,556 | 45,312 | - | - | Stock Option (right to buy) | |
| Grant Verstandig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 39,096 | 39,096 | - | - | Stock Option (right to buy) |